Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (19)
- Safety monitoring and information (12)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Legislation (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
Collection content
110 result(s) found, displaying 101 to 110
-
FormsSubmission dossier checklist for prescription medicines
-
Medicine shortage alertsTHE SHORTAGE HAS RESOLVED AND THE SSSI WILL LAPSE ON 31 MARCH 2026.
-
CommitteeInformation on the role and membership of ACM and proposed meeting dates.
-
Medicine shortage alertsConcerta modified-release tablets will remain in shortage at various times until the end of 2026
-
Medicine shortage alertsClinical guidance for prescribers during the shortages is available.
-
Medicine shortage alertsWe have approved overseas-registered substitutes for Pegasys 135 micrograms/0.5 mL and 180 micrograms/0.5 mL pre-filled syringes.
-
Medicine shortage alertsRitalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.
-
Medicine shortage alertsPharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.
-
Corporate reportsThese guidelines apply to company-sponsored post-marketing surveillance studies of drug safety and toxicity
-
Corporate reportsTGA approach to disclosure of commercially confidential information (CCI)